Pseudo-Meigs' syndrome secondary to an ovarian germ cell tumor

Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trial.

ESMO open·2026

Genomic correlates of response and resistance to the irreversible FGFR1-4 inhibitor futibatinib based on biopsy and circulating tumor DNA profiling.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.

British journal of cancer·2017

A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?

British journal of cancer·2014

A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer.

British journal of cancer·2010

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

British journal of cancer·2005

Long-term efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer: Results of a 2-year follow-up of ENGOT-OV60/GOG-3052/RAMP 201.

Gynecologic oncology·2026

Prognostic implications of HPV and TP53 status in early-stage vulvar squamous cell carcinoma.

Gynecologic oncology·2026

Planning and feasibility of phase III surgical trials in gynecologic oncology.

Gynecologic oncology·2026

Minimally invasive surgery without a uterine manipulator versus open radical hysterectomy for early-stage cervical cancer: A retrospective propensity-score-matched single-center cohort study.

Gynecologic oncology·2026

Mutated p53 results in altered type I interferon pathway expression and signaling in endometrial cancer.

Gynecologic oncology·2026

Molecular groups predict response to fertility-sparing treatment of endometrial carcinoma: a systematic review and metanalysis.

Gynecologic oncology·2026

Unmasking the Unexpected: Renal Arteriovenous Malformation in a Young Puerto Rican Patient With Persistent Hypertension.

Cureus·2026

Hybrid robotic transversus abdominis release (hrTAR) for complex ventral hernias: a systematic review and preliminary synthesis.

Journal of robotic surgery·2026

ERRATUM: Effect of the duration of visual exposure to the male on the reproductive performance of nulliparous guinea pigs.

Brazilian journal of veterinary medicine·2026

A Rare Finding of Mosaic 45,XX,der(13;21)(q10;q10)[15]/46,XX,r(13)(p11.2q33) Following Abnormal Prenatal Chromosomal Microarray Testing.

Case reports in genetics·2026

Corrigendum to "Determination of human papillomavirus prevalence in the female population from Zanjan, Iran" [Prev. Med. Rep. 62 (2026) 103406].

Preventive medicine reports·2026

A Rare Mimicker: Renal Endometriosis and Its Diagnostic Pitfalls-Review of Reported Cases.

Diagnostics (Basel, Switzerland)·2026

Related Experiment Videos

Pseudo-Meigs' syndrome secondary to an ovarian germ cell tumor

Related Concept Videos

Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trial.

Genomic correlates of response and resistance to the irreversible FGFR1-4 inhibitor futibatinib based on biopsy and circulating tumor DNA profiling.

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.

A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?

A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer.

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

Long-term efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer: Results of a 2-year follow-up of ENGOT-OV60/GOG-3052/RAMP 201.

Prognostic implications of HPV and TP53 status in early-stage vulvar squamous cell carcinoma.

Planning and feasibility of phase III surgical trials in gynecologic oncology.

Minimally invasive surgery without a uterine manipulator versus open radical hysterectomy for early-stage cervical cancer: A retrospective propensity-score-matched single-center cohort study.

Mutated p53 results in altered type I interferon pathway expression and signaling in endometrial cancer.

Molecular groups predict response to fertility-sparing treatment of endometrial carcinoma: a systematic review and metanalysis.

Unmasking the Unexpected: Renal Arteriovenous Malformation in a Young Puerto Rican Patient With Persistent Hypertension.

Hybrid robotic transversus abdominis release (hrTAR) for complex ventral hernias: a systematic review and preliminary synthesis.

ERRATUM: Effect of the duration of visual exposure to the male on the reproductive performance of nulliparous guinea pigs.

A Rare Finding of Mosaic 45,XX,der(13;21)(q10;q10)[15]/46,XX,r(13)(p11.2q33) Following Abnormal Prenatal Chromosomal Microarray Testing.

Corrigendum to "Determination of human papillomavirus prevalence in the female population from Zanjan, Iran" [Prev. Med. Rep. 62 (2026) 103406].

A Rare Mimicker: Renal Endometriosis and Its Diagnostic Pitfalls-Review of Reported Cases.

Related Experiment Videos

Pseudo-Meigs' syndrome secondary to an ovarian germ cell tumor

Related Concept Videos

Related Articles